Human iPSC-derived preclinical models to identify toxicity of tumor-specific T cells with clinical potential
Authors | van Amerongen R, Morton L, Chaudhari U, Remst D, Hagedoorn R, van den Berg C, Freund C, Falkenburg J, Heemskerk M. |
---|---|
Journal | Mol Ther Methods Clin Dev |
Publication Date | 2023-01-20 |
PubMed | 36816758 |
PubMed Central | PMC9931760 |
DOI | 10.1016/j.omtm.2023.01.005 |